Événements S-GE Country Event: Opportunités de business en Inde May 22, 2024 16:15–19:00 Lugano Switzerland
Event S-GE Country Event: Geschäftsmöglichkeiten in Indien May 22, 2024 16:15–19:00 Lugano Switzerland
Fact Sheet Mar 25, 2024 Market access in France - healthcare sector Our factsheet below provides an overview of the specifics of a reimbursement-based healthcare market, its players, procedures and purchasing chan...
S-GE Event Country Event: Business opportunities in India May 22, 2024 16:15–19:00 Lugano Switzerland
Viaggi per imprenditori Fact Finding Mission: Chongqing, Dalian/Liaoyang & Pechino Jun 24, 2024–Jun 28, 2024 China
News Apr 23, 2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
Evento S-GE Country Event: Opportunità di business in India May 22, 2024 16:15–19:00 Lugano Switzerland
News Apr 09, 2024 Sitem Startup Club and CSEM forge a strategic partnership to propel medtech innovation Sitem Startup Club (SSC) has officialized a partnership with CSEM, uniting Bern's medtech ecosystem with engineering excellence for transformativ...
News Mar 20, 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
Actualités Apr 23, 2024 Les orthèses de poignet innovantes imprimées en 3D de Swibrace passent à la phase clinique Swibrace, en partenariat avec l’Inselspital de Berne, fait passer ses attelles de poignet personnalisées en phase clinique, améliorant ainsi le t...
Factsheet Mar 25, 2024 Marktzugang in Frankreich – Gesundheitssektor Das nachstehende Factsheet enthält einen Überblick über die Besonderheiten eines erstattungsbasierten Gesundheitsmarktes, seine Akteure, Verfahre...
News Oct 10, 2023 Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing Propelling the momentum towards humane, next-gen laboratory solutions, Nagi Bioscience has secured CHF 12.4 million to open doors to new markets ...